Clinical Trial Update: Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma [Phase 2]

View source ↗

Summary

Clinical trial update indicates SHR-4597 inhalant is being studied for asthma in adults, currently in Phase 2 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SHR-4597 Inhalant (SHR-4597)

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Asthma | Phase 2 | Status: NOT_YET_RECRUITING